Roche Holding AG to acquire Santaris Pharma to expand discovery and development of RNA-targeting medicines


Sunday, 3 Aug 2014 08:00pm EDT 

Roche Holding AG:Says to acquire Santaris Pharma to expand discovery and development of RNA-targeting medicines.Says acquisition is expected to close in Aug. 2014.Plans to maintain Santaris Pharma’s operations in Denmark, where existing site to be renamed Roche Innovation Center Copenhagen.Says under terms of agreement, Roche to make upfront cash payment of $250 million to Santaris Pharma shareholders and make additional contingent payments of up to $200 million based on achievement of certain predetermined milestones. 

Company Quote

37.63
0.15 +0.40%
17 Sep 2014